by Gordon Hensley | Feb 21, 2019 | advocacy, Business, CMS, health care, lobbying, Medicare Cuts, Pharma, U.S. House, U.S. Senate
Among the most complex but significant issues in the unfolding debate about prescription drug pricing reform is pharmacy benefit manager (PBM) rebates — or, so-called “rebates” — as many objective observers see them as kickbacks or opaque...
by Gordon Hensley | Mar 1, 2018 | advocacy, Business, CMS, health care, Pharma, SNF
It’s an election year. Congress has to appear to be “doing something” about the opioid epidemic engulfing communities across the U.S. The good news, it is: Senator Rob Portman (R-OH) introduced a bipartisan bill this week, the “CARA 2.0 Act of...